Medicus Pharma Ltd. MDCXW

Set alert

Price alert · MDCXW

All alert types
0.21 USD 0.00 -0.05%

As of Oct 29, 11:14 AM ET

Bid
0.20 × 1
Ask
0.27 × 1
0.21 Day range 0.21
0.21 52-week range 0.21
YTD
0.00%
1 year
0.00%
Open
0.9899
Prev close
0.2101
Mkt cap
3.76M
Vol
250
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.21
High
0.21
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MDCXW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.71 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.8×
FY 2021: -10.2×FY 2022: -16.6×FY 2023: -5.4×FY 2024: -3.5×FY 2025: -0.8×
FY 2021 5y median -5.4× FY 2025
P/S 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -391×
FY 2021: -2.0×FY 2022: -1.8×FY 2023: 19.3×FY 2024: 9.2×FY 2025: -391×
FY 2021 5y median -1.8× FY 2025
P/FCF -1.2×
FY 2021: -14.7×FY 2022: -20.2×FY 2023: -5.1×FY 2024: -2.8×FY 2025: -1.2×
FY 2021 5y median -5.1× FY 2025
EV/EBITDA -0.9×
FY 2021: -11.3×FY 2022: -19.4×FY 2023: 10.9×FY 2024: -2.2×FY 2025: -0.9×
FY 2021 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -86.1%
FY 2021: -6.8%FY 2022: -4.9%FY 2023: -19.4%FY 2024: -35.7%FY 2025: -86.1%
FY 2021 5y median -19.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 37549.8%
FY 2021: 19.6%FY 2022: 13.9%FY 2023: -478.2%FY 2024: -355.9%FY 2025: 37549.8%
FY 2021 5y median 13.9% FY 2025
ROIC -452.4%
FY 2021: 14.7%FY 2022: 9.2%FY 2023: -425.6%FY 2024: -323.4%FY 2025: -452.4%
FY 2021 5y median -323.4% FY 2025
ROA -252.1%
FY 2021: -2617.7%FY 2022: -598.8%FY 2023: -280.8%FY 2024: -197.6%FY 2025: -252.1%
FY 2021 5y median -280.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 FY 2025
Operating Income -64.1%
FY 2021: 0.0%FY 2022: 32.1%FY 2023: -383.4%FY 2024: -136.4%FY 2025: -64.1%
FY 2021 FY 2025
EPS (diluted) -184.1%
FY 2021: 0.0%FY 2022: 38.5%FY 2023: -206.3%FY 2024: -40.8%FY 2025: -184.1%
FY 2021 FY 2025
Free Cash Flow -122.3%
FY 2021: 0.0%FY 2022: 27.0%FY 2023: -293.4%FY 2024: -146.4%FY 2025: -122.3%
FY 2021 FY 2025

Financial Health

Current Ratio 1.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 2.4×FY 2024: 2.3×FY 2025: 1.0×
FY 2021 5y median 1.0× FY 2025
Quick Ratio 1.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 2.4×FY 2024: 2.3×FY 2025: 1.0×
FY 2021 5y median 1.0× FY 2025
Debt / Equity -59.1×
FY 2021: -0.1×FY 2022: -0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: -59.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2021: -0.3×FY 2022: -1.1×FY 2023: -1.0×FY 2024: 0.3×FY 2025: 0.2×
FY 2021 5y median -0.3× FY 2025
Interest Coverage -130×
FY 2021: -12.5×FY 2022: -1.9×FY 2023: -7.9×FY 2024: -35.2×FY 2025: -130×
FY 2021 5y median -12.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31